Sistema's IFRS loss for 2024 amounted to ₽11 billion, doubling from ₽5.3 billion in the previous year. Revenue rose 17.1% to ₽1.23 trillion against ₽1.05 trillion a year earlier.

Sistema's RAS loss for 2024 amounted to ₽58.2 billion against a profit of ₽50 billion in the previous year. Revenue increased by 16% to ₽32.7 billion against ₽28.2 billion a year earlier.

Chain of private clinics Medsi is looking for a contractor to supply medical equipment and furniture for its clinic in the capital of Tajikistan, Dushanbe, according to tender materials reviewed by Vedomosti. In January, Medsi also identified a supplier of diagnostic equipment for the clinic.

Binnopharm Group will start selling two hormonal drugs for the treatment of endometriosis in Russia in May this year, and in the future will consider localization of their production. Now the company is actively building a gynecological portfolio, which will include these and several other drugs. In the coming year, the company plans to launch a total of fiv...